Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15785140 | 0.85 | — | — | |
| SCHEMBL27670891 | 0.74 | — | — | |
| SCHEMBL30837405 | 0.72 | — | — | |
| SCHEMBL15768400 | 0.69 | — | — | |
| SCHEMBL9463586 | 0.67 | — | — | |
| SCHEMBL27836870 | 0.65 | — | — | |
| SCHEMBL25240388 | 0.65 | — | — | |
| SCHEMBL16668729 | 0.65 | — | — | |
| SCHEMBL1184495 | 0.65 | — | — | |
| SCHEMBL16668733 | 0.63 | LMNA (0.33) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188609-A1 | SEAM-FREE AND CRACK-FREE DEPOSITION | LAM RES CORP (US) | 2025-06-12 | — | — | US | disclosed |
| US-20250054747-A1 | CONFORMAL DEPOSITION OF SILICON NITRIDE | LAM RES CORP (US) | 2025-02-13 | — | — | US | disclosed |
| US-20250038003-A1 | LOW TEMPERATURE MOLYBDENUM DEPOSITION ASSISTED BY SILICON-CONTAINING REACTANTS | LAM RESEARCH CORPORATION (US) | 2025-01-30 | — | — | US | disclosed |
| US-20250014890-A1 | CONFORMAL, CARBON-DOPED SILICON NITRIDE FILMS AND METHODS THEREOF | LAM RESEARCH CORPORATION | 2025-01-09 | — | — | US | disclosed |
| CN-119213529-A | Seamless and crack-free deposition | 朗姆研究公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024243002-A1 | LOW PRESSURE CHEMICAL VAPOR DEPOSITION OF SILICON OXIDE | LAM RESEARCH CORPORATION (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240030062-A1 | INTEGRATION OF FULLY ALIGNED VIA THROUGH SELECTIVE DEPOSITION AND RESISTIVITY REDUCTION | LAM RESEARCH CORPORATION | 2024-01-25 | — | — | US | disclosed |
| CN-117121173-A | Integration of fully aligned vias by selective deposition and resistivity reduction | 朗姆研究公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023178203-A1 | SEAM-FREE AND CRACK-FREE DEPOSITION | LAM RESEARCH CORPORATION (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023114641-A1 | CONFORMAL DEPOSITION OF SILICON NITRIDE | LAM RESEARCH CORPORATION (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023102440-A1 | CONFORMAL, CARBON-DOPED SILICON NITRIDE FILMS AND METHODS THEREOF | LAM RESEARCH CORPORATION (US) | 2023-06-08 | — | — | WO | disclosed |
| WO-2022221881-A1 | INTEGRATION OF FULLY ALIGNED VIA THROUGH SELECTIVE DEPOSITION AND RESISTIVITY REDUCTION | LAM RESEARCH CORPORATION (US) | 2022-10-20 | — | — | WO | disclosed |
| US-10899500-B2 | Alkoxysilylamine compounds and applications thereof | VERSUM MATERIALS US, LLC (US) | 2021-01-26 | — | — | US | disclosed |
| US-20190225377-A1 | Alkoxysilylamine Compounds and Applications Thereof | VERSUM MATERIALS US, LLC (US) | 2019-07-25 | — | — | US | disclosed |
| US-10279959-B2 | Alkoxysilylamine compounds and applications thereof | VERSUM MATERIALS US, LLC (US) | 2019-05-07 | — | — | US | disclosed |
| EP-2743272-B1 | Alkoxysilylamine compounds and applications thereof | AIR PROD & CHEM (US) | 2016-11-02 | — | — | EP | disclosed |
| EP-2743272-A1 | Alkoxysilylamine compounds and applications thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-06-18 | — | — | EP | disclosed |
| US-20140158580-A1 | ALKOXYSILYLAMINE COMPOUNDS AND APPLICATIONS THEREOF | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225377-A1 | Alkoxysilylamine Compounds and Applications Thereof | C5, C1S, C3AR1 | LMNA 2277/4885 |
| US-20250014890-A1 | CONFORMAL, CARBON-DOPED SILICON NITRIDE FILMS AND METHODS THEREOF | CNTN1, NCDN, SEPTIN6 | LMNA 1501/4885 |
| US-10899500-B2 | Alkoxysilylamine compounds and applications thereof | C5, C1S, C3AR1 | LMNA 2277/4885 |
| US-10279959-B2 | Alkoxysilylamine compounds and applications thereof | C3AR1, C5, ALK | LMNA 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.